Medgenics (MDGN) Reports Q4 Loss of $0.30/Share
Tweet
Share
E-mailGet Alerts MDGN Hot Sheet
Join SI Premium – FREE
Medgenics (NYSE: MDGN) reported Q4 EPS of ($0.30), versus ($0.28) reported last year.
For earnings history and earnings-related data on Medgenics (MDGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Ascendis Pharma (ASND) Tops Q2 EPS by 132c
- Mount Logan's Ability Insurance launches MYGA annuity products
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
